In colorectal cancer, high CMTM6 levels are associated with an inflamed tumor microenvironment, while in hepatocellular carcinoma, CMTM6 inhibits cell proliferation by preventing p21 ubiquitination [15,20]. This evidence concerns the gene CMTM6 and hepatocellular carcinoma.